According to the expression levels of HOXB-AS3, the MDS patients was stratified into four groups, lowest, intermediate low, intermediate high, and highest HOXB-AS3 expression groups (Additional file 1: Figure S14). This evidence concerns the gene PDS5B and myelodysplastic syndrome.